Please login to the form below

Not currently logged in
Email:
Password:

iniparib

This page shows the latest iniparib news and features for those working in and with pharma, biotech and healthcare.

AZ's Lynparza cleared for ovarian cancer in Europe

AZ's Lynparza cleared for ovarian cancer in Europe

Sanofi was forced to abandon development of its iniparib candidate, which had been in trials for breast and non-small cell lung cancer (NSCLC).

Latest news

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics